D-bait: A siDNA for regulation of DNA-protein kinases against DNA damage and its implications in cancer

被引:0
|
作者
Sengar, Devyani [1 ,2 ]
Pathan, Nida Sayed [1 ,2 ]
Gajbhiye, Virendra [1 ,2 ]
机构
[1] Agharkar Res Inst, Nanobioscience Grp, Pune 411004, India
[2] Savitribai Phule Pune Univ, Pune 411007, India
关键词
Dbait; DNA-dependent protein kinase; PARP inhibition; Radiosensitization; DNA damage response; REPAIR INHIBITOR DBAIT; DOUBLE-STRAND BREAKS; PROSTATE-CANCER; PERITONEAL CARCINOMATOSIS; HEPATOCELLULAR-CARCINOMA; CYTOREDUCTIVE SURGERY; SYNTHETIC LETHALITY; CATALYTIC SUBUNIT; IN-VITRO; CELLS;
D O I
10.1016/j.ijpharm.2025.125416
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
siDNA fragments, also called Dbait and Pbait, are small DNA oligonucleotides of 30-32 base pairs that cause impairment in DNA repair pathways. Like siRNA and miRNA molecules, which lead to the degradation of mRNA molecules through the Argonaute and Drosha machinery, respectively, Dbait molecules act as false DNA damage signals and trigger and exhaust the DNA repair machinery. In normal cells with no significant DNA damage, the influence of these molecules is negligible. However, in cancer, when there is heavy DNA damage due to replication and anticancer therapies, the cancer cell is heavily dependent on DNA repair proteins to keep the genome intact and limit breaks. This phenomenon primarily occurs during radiation therapy, as significant DNA damage surpasses several DNA repair mechanisms, causing an accumulation of unrepaired lesions and ultimately leading to cell death. This review explores the therapeutic capacity of siDNA molecules in cancer treatment by stimulating the repair mechanisms in cells that depend on DNA repair pathways. For aggressive malignancies such as glioblastoma, prostate cancer, and colorectal cancer, the use of siDNA as a radiosensitizer, especially when combined with other treatments, increases the vulnerability of tumor cells to radiation-induced DNA damage, hence potentially enhancing therapy results.
引用
收藏
页数:17
相关论文
共 9 条
  • [1] DNA damage repair in breast cancer and its therapeutic implications
    Ali, Reem
    Rakha, Emad A.
    Madhusudan, Srinivasan
    Bryant, Helen E.
    PATHOLOGY, 2017, 49 (02) : 156 - 165
  • [2] Structure of DNA-dependent protein kinase: implications for its regulation by DNA
    Leuther, KK
    Hammarsten, O
    Kornberg, RD
    Chu, G
    EMBO JOURNAL, 1999, 18 (05): : 1114 - 1123
  • [3] DNA damage response and repair in colorectal cancer: Defects, regulation and therapeutic implications
    Mirza-Aghazadeh-Attari, Mohammad
    Darband, Saber Ghazizadeh
    Kaviani, Mojtaba
    Mihanfar, Ainaz
    Attari, Javad Aghazadeh
    Yousefi, Bahman
    Majidinia, Maryam
    DNA REPAIR, 2018, 69 : 34 - 52
  • [4] DNA damage response and prostate cancer: defects, regulation and therapeutic implications
    Karanika, S.
    Karantanos, T.
    Li, L.
    Corn, P. G.
    Thompson, T. C.
    ONCOGENE, 2015, 34 (22) : 2815 - 2822
  • [5] Protein kinase D1 mitigation against etoposide induced DNA damage in prostate cancer is associated with increased α-Catenin
    Shukla, Sanjeev
    Osumi, Teruko
    Al-Toubat, Mohammed
    Serrano, Samuel
    Singh, Pankaj kumar
    Mietzsch, Mario
    McKenna, Robert
    Chardon-Robles, Jonathan
    Krishnan, Sunil
    Balaji, K. C.
    PROSTATE, 2025, 85 (02): : 156 - 164
  • [6] Role of EMT in the DNA damage response, double-strand break repair pathway choice and its implications in cancer treatment
    Moyret-Lalle, Caroline
    Prodhomme, Melanie K.
    Burlet, Delphine
    Kashiwagi, Ayaka
    Petrilli, Virginie
    Puisieux, Alain
    Seimiya, Hiroyuki
    Tissier, Agnes
    CANCER SCIENCE, 2022, 113 (07) : 2214 - 2223
  • [7] The DNA damage response: a common pathway in the regulation of NKG2D and DNAM-1 ligand expression in normal infected, and cancer cells
    Cerbonil, Cristina
    Fionda, Cinzia
    Soriani, Alessandra
    Zingoni, Alessandra
    Doria, Margherita
    Cippitelli, Marco
    Santoni, Angela
    FRONTIERS IN IMMUNOLOGY, 2014, 4
  • [8] Induction of DNA damage and p21-dependent senescence by Riccardin D is a novel mechanism contributing to its growth suppression in prostate cancer cells in vitro and in vivo
    Zhongyi Hu
    Denglu Zhang
    Jianrong Hao
    Keli Tian
    Wei Wang
    Hongxiang Lou
    Huiqing Yuan
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 397 - 407
  • [9] Induction of DNA damage and p21-dependent senescence by Riccardin D is a novel mechanism contributing to its growth suppression in prostate cancer cells in vitro and in vivo
    Hu, Zhongyi
    Zhang, Denglu
    Hao, Jianrong
    Tian, Keli
    Wang, Wei
    Lou, Hongxiang
    Yuan, Huiqing
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (02) : 397 - 407